Who
Richard Giroux
CFO & COO
Company insider
Files Form 4 as: CFO & COO, MeiraGTx Holdings.
In numbers
- Trades disclosed
- 92
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $5.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2018
- Last trade
- 20 Oct 2026
- Last filed
- 20 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Oct 2026filed 20 Oct 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $557K56,000 at $9.95 | filing |
| 21 Jul 2026filed 21 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $701K56,000 at $12.51 | filing |
| 21 Jul 2026filed 21 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $701K56,000 at $12.51 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —980,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —980,000 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 21 Apr 2026filed 21 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $572K56,000 at $10.22 | filing |
| 21 Apr 2026filed 21 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $572K56,000 at $10.22 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —60,000 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $236K31,726 at $7.45 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —60,000 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $236K31,726 at $7.45 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —310,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $1.2M163,916 at $7.42 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —310,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —310,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —310,000 | filing |
News
No headline names them, or the companies they trade most, lately.